Treatment of venous thromboembolism: duration and new options

Hematol J. 2004:5 Suppl 3:S24-8. doi: 10.1038/sj.thj.6200417.
No abstract available

Publication types

  • Review

MeSH terms

  • Anticoagulants / administration & dosage
  • Anticoagulants / therapeutic use*
  • Azetidines / therapeutic use
  • Benzylamines
  • Clinical Trials, Phase III as Topic
  • Drug Design
  • Factor Xa Inhibitors
  • Follow-Up Studies
  • Fondaparinux
  • Humans
  • Polysaccharides / administration & dosage
  • Polysaccharides / therapeutic use
  • Randomized Controlled Trials as Topic
  • Recurrence
  • Thromboembolism / drug therapy*
  • Thromboembolism / etiology
  • Thromboembolism / prevention & control
  • Thrombophilia / complications
  • Venous Thrombosis / drug therapy*
  • Venous Thrombosis / etiology
  • Venous Thrombosis / prevention & control
  • Vitamin K / antagonists & inhibitors

Substances

  • Anticoagulants
  • Azetidines
  • Benzylamines
  • Factor Xa Inhibitors
  • Polysaccharides
  • Vitamin K
  • ximelagatran
  • Fondaparinux